Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The polyamine metabolic pathway encompasses the biosynthesis, catabolism, and transport of polyamines—small aliphatic polycations such as putrescine, spermidine, and spermine. These molecules are ubiquitous in living organisms and play essential roles in cellular functions including nucleic acid synthesis, protein synthesis, cell growth, and proliferation. The pathway is tightly regulated to maintain intracellular homeostasis through coordinated control of enzyme activity and transport systems. Dysregulation of the polyamine metabolic pathway has been implicated in cancer development/progression, immune response modulation, and other diseases. Because rapidly proliferating cells require increased levels of polyamines, the pathway represents a rational target for therapeutic intervention—especially in oncology where inhibitors targeting key enzymes have been developed or proposed.
Targeted inhibition of key enzymes in the polyamine biosynthesis pathway.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyamine Metabolic Pathway.